Authors: | Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; Matasar, M. J.; Mccall, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; Portlock, C. S.; Straus, D. J.; Verwys, S.; Zelenetz, A. D.; Zhang, Z. G.; Younes, A.; Moskowitz, C. H. |
Abstract Title: | Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma |
Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 124 |
Issue: | 21 |
Meeting Dates: | 2014 Dec 6-9 |
Meeting Location: | San Francisco, CA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2014-12-06 |
Language: | English |
ACCESSION: | WOS:000349243501070 |
PROVIDER: | wos |
DOI: | 10.1182/blood.V124.21.3085.3085 |
Notes: | Meeting Abstract: 3085 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |